UBS downgrades First Horizon stock rating on limited upside By Investing.com - ca.investing.com

UBS downgraded First Horizon National (FHN) to Neutral from Buy and lowered its price target to $25 from $29, citing limited upside without another M&A and noting management may pursue acquisitions. The shares trade at a P/E of 12.45 and PEG of 0.31; InvestingPro flags FHN as overvalued vs fair value while fiscal 2026 EPS is forecast at $2.12 and UBS’s FY26–27 EPS estimates sit 1%–4% below consensus. Corporate actions include a 13% quarterly dividend increase to $0.17 payable Apr 1, 2026, redemption of Series C preferred on May 1, 2026 at $25 per depositary share ($10,000 per Series C share), and completion of a 16 million depositary-share sale of Series H preferred.

Analysis

The market has been pricing a valuation premium into this regional bank that looks contingent on an external event (M&A) or visible execution on fee and deposit initiatives. If that conditional outcome fails to materialize the most likely mechanism for multiple compression is investors re-pricing the firm back toward peer-mean multiples within 3–12 months; empirically, such re-ratings in the regional-banking cohort move 20–30% when acquirer/takeover optionality evaporates.

Capital-liability moves (active use of hybrid instruments and targeted redemptions) shift the near-term cash-flow profile and change dilution/leverage math even if they improve regulatory ratios; the second-order effect is a transient increase in supply of quasi-equity that can depress common shares while improving reported CET1, creating a mismatch between risk assets and headline capital metrics over 6–18 months. Underwriters’ involvement and timing windows matter — periods of concentrated issuance are when equity is most vulnerable to sentiment-driven outflows.

Operational hires focused on deposit product management and wealth portfolio construction are credible levers to de-risk an asset-sensitive margin position, but execution lag is real: expect measurable improvements to deposit beta and fee income only over multiple quarters. The immediate trade-off is binary — either the firm is re-valued lower as an acquirer or it gradually justifies a premium through execution; monitoring deposit beta, wealth AUM flows, and any use of stock as M&A currency will be the high-conviction signal set over the next 3–12 months.

Key Decisions for Investors

• Short FHN equity or buy 6–9 month put spreads (defined-risk): target a 20–30% downside to capture premium unwinding; risk limited to option premium or set a 15% stop on a short equity position if deposit/wealth KPIs beat expectations within two quarters.
• Pair trade: short FHN / long C (or MS) for 3–9 months to isolate idiosyncratic re-rating risk while maintaining sector exposure; position size the short leg 50–75% of the long to limit systemic bank-cycle risk. Expect 1.5–2.5x asymmetric return if FHN de-rates while majors hold multiple.
• Buy newly issued high-coupon preferred (or series-H style depositary shares) in secondary for carry if call risk is limited; horizon 6–18 months to capture spread compression vs common equity, but hedge with a short-common position sized to neutralize large equity downside.
• Watch triggers (earnings vs. deposit beta, announced M&A intent, capital raises): if any of these flip positive, cover shorts and consider a small long common position or long-dated call spread to play a confirmed re-rating — otherwise keep exposure small and defined-risk.